Tilray FY26 net loss narrows to $105.16 million; revenue rises 11% to $915.45 million

Tilray Brands posted fiscal 2026 net revenue up 11% to $915.5 million; fourth-quarter net revenue climbed 25% to $281.7 million.

Fiscal 2026 net loss narrowed to $105.2 million, or $1.09 per share; fourth-quarter net loss narrowed to $37.9 million, or $0.43 per share.

Non-GAAP adjusted EBITDA rose 11% to $61.1 million for fiscal 2026; fourth-quarter adjusted EBITDA increased 15% to $31.9 million.

International medical cannabis revenue increased 34% for fiscal 2026; Tilray highlighted the BrewDog acquisition as accelerating its global beverage platform expansion.

Tilray ended fiscal 2026 with about $235 million in cash, restricted cash and marketable securities; fiscal 2027 adjusted EBITDA is guided at $68 million to $75 million.